Nexgel (NXGL) Return on Sales (2018 - 2025)

Nexgel's Return on Sales history runs 8 years deep, the most recent figure standing at 0.0% for Q4 2025.

• Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Sales was 0.0% for Q4 2025 at Nexgel, down from 0.0% in the prior quarter.
• Across five years, Return on Sales topped out at 0.0% in Q3 2025 and bottomed at 0.05% in Q1 2022.
• A 5-year average of 0.01% and a median of 0.01% in 2024 frame the typical range for Return on Sales.
• Annual changes were most pronounced in 2021 — Return on Sales gained 5 bps — and 2022, when it slipped 2 bps.
• Nexgel's Return on Sales stood at 0.03% in 2021, then surged by 63 bps to 0.01% in 2022, then grew by 11 bps to 0.01% in 2023, then surged by 75 bps to 0.0% in 2024, then dropped by 22 bps to 0.0% in 2025.
• Business Quant data shows NXGL's Return on Sales at 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.